Stay updated on NasoVAX in Early COVID-19 Clinical Trial

Sign up to get notified when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NasoVAX in Early COVID-19 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T19:26:41.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces that the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T19:28:04.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:06:28.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site revision label changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-10T22:04:20.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 tag appears on the page, marking the current revision level of the study record on ClinicalTrials.gov. This is a metadata update and does not reflect substantive changes to the study data, outcomes, eligibility criteria, or sites.
    Difference
    18%
    Check dated 2026-09-19T20:59:07.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a minor site update. This change does not modify any study details or visible content.
    Difference
    0.1%
    Check dated 2026-08-29T19:46:50.000Z thumbnail image

Stay in the know with updates to NasoVAX in Early COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.